(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
The most effective method to Pick the Right Teeth Substitution Choice for You - 2Investigate These Retreats Well known With Seniors
- 3New law puts familiar drinks, creams and gummies in legal limbo
- 4A definitive Manual for the 5 Off-road Bicycles Available
- 5Tzrifin base exhibition reveals Hamas and Hezbollah arms, showing structure behind attacks
- Instructions to Pick the Right Senior Protection Plan.
- Explainer-Why are hepatitis B vaccines given to newborns?
- The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
- Figure out How to Explore the Infotainment Framework in the Slam 1500.
- Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- Chicago reports first rabies-positive dog in 61 years. What we know.
- Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
